PBzyme drives intrinsic anti-oxidative and anti-inflammatory bioactivities to achieve good preventive therapeutic efficacy for AP by inhibiting TLRs/NF-κB signaling pathways related to inflammation and oxidative stress, and by scavenging ROS. Here, NFKB1 is linked to alkaline phosphatase measurement.